AI is redefining the future of hepatology drug development. Understanding how to leverage this emerging technology is a key element in optimizing clinical trial timelines and costs.
Access the report to discover:
- How AI supports smarter site selection and patient matching.
- The potential to replace invasive biopsies with AI-driven imaging.
- How federated learning enables insights without centralizing data.
- Key ethical and regulatory considerations for AI in trials.
- The path toward personalized medicine in hepatology.